🟢 Mirum Pharmaceuticals is trading 12.4% up in pre-market ahead of November 3 third-quarter results

Mirum Pharmaceuticals is trading at $95.50, up 12.35% in pre-market, with its upcoming third-quarter report potentially drawing investor attention.

• The company is due to report third-quarter 2026 results after the market closes on November 3; it announced the reporting date on October 27.
• No company announcement explaining the pre-market jump was found. The Nasdaq is up 0.86% and the S&P 500 is up 0.52%, both smaller gains than the stock’s move.